documents: FDA-2026-D-1255-0002
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2026-D-1255-0002 | FDA | FDA-2026-D-1255 | Safety Assessment of Genome Editing in Human Gene Therapy Products Using Next-Generation Sequencing; Draft Guidance for Industry | Other | Guidance | 2026-04-15 | 2026 | 4 | 2026-04-15 | 2026-07-15 | 2026-04-16 09:00:16 | 1 | 0 | 09000064b9282a2a |